GSK, Teva Say Lamictal Deal Doesn't Break Antitrust Law
GlaxoSmithKline LLC and Teva Pharmaceutical Industries Ltd. urged a New Jersey federal judge Friday to dismiss claims by indirect purchasers of GSK's epilepsy drug Lamictal accusing the companies of entering a...To view the full article, register now.
Already a subscriber? Click here to view full article